InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.8070
-0.0081 (-0.99%)
At close: Aug 8, 2025, 4:00 PM
0.8165
+0.0095 (1.18%)
After-hours: Aug 8, 2025, 7:53 PM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $54.67 million as of August 8, 2025. Its market cap has decreased by -35.97% in one year.
Market Cap
54.67M
Enterprise Value
39.64M
1-Year Change
-35.97%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $351.36M to $54.67M, a decrease of -84.44%. That is a compound annual growth rate of -21.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 55.22M | -62.03% |
| Dec 31, 2024 | 145.44M | 51.53% |
| Dec 29, 2023 | 95.98M | -29.96% |
| Dec 30, 2022 | 137.03M | -34.85% |
| Dec 31, 2021 | 210.33M | 48.13% |
| Dec 31, 2020 | 141.99M | 37.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |